Pune: Krsnaa Diagnostics Ltd, one of India’s largest providers of integrated diagnostic services, has announced a strategic investment in Apulki Healthcare Private Limited (‘Apulki’), India’s first Public Private Partnership (PPP) dedicated for cancer and cardiac care hospital. Under this collaboration, Krsnaa will deliver a comprehensive suite of integrated diagnostic services at Apulki’s facilities, enhancing access to advanced and super specialized diagnostics.
Under this collaboration, Krsnaa Diagnostics will become the exclusive diagnostics partner for Apulki’s state-of-the-art cancer and cardiac hospitals for the next 30+ years. This ensures Krsnaa’s sustained leadership in the high-growth oncology and cardiac diagnostic segments, with access to Apulki’s planned network of 10+ hospitals across India. The initial rollout includes two advanced 125+ bedded hospitals in densely populated regions of Pune and Mumbai, with more hospitals to follow in other metropolitan areas. This initiative will cater to the unmet demand for specialized diagnostics, helping improve outcomes for patients from all socioeconomic backgrounds.
By offering a comprehensive suite of cutting-edge diagnostic technologies—including MRI, PET CT, Cardiac CT, and Advanced Pathology—available 24×7 under one roof, Krsnaa and Apulki will provide seamless, world-class diagnostic services for patients undergoing cancer and cardiac treatment. The goal of this partnership is to accelerate early detection, enhance treatment accuracy, and ultimately, improve survival rates through timely and accurate diagnoses.
Mr. Yash Mutha, Joint Managing Director of Krsnaa Diagnostics Ltd, stated, “This investment is more than just a strategic partnership; it is a game-changer in the Indian healthcare landscape. By acquiring a stake in Apulki, we are positioning ourselves at the forefront of the rapidly expanding cancer and cardiac care segment. The investment is subject to fulfilment of certain conditions precedent, and the exact amount will be disclosed once we sign the definitive documents. However, it is important to note that this investment will not put any strain on our cash flows, as it will be funded entirely through internal accruals over the next 2-3 months. This partnership also marks a significant milestone for Krsnaa on the retail front, as it enables us to establish comprehensive diagnostic centers in premium urban locations. Through this collaboration, we will not only serve the captive patients within the hospitals but also cater to the growing number of retail patients seeking advanced diagnostics in these urban areas. We are committed to delivering high-quality, affordable diagnostics, and this partnership aligns perfectly with our vision of making advanced healthcare accessible to all. This also strengthens Krsnaa’s portfolio, opening avenues for sustainable long-term growth and shareholder value.”
Ms. Kinjal Babariya, Director of Apulki Healthcare Private Limited, commented, “We are thrilled to join forces with Krsnaa Diagnostics, a trusted name in the diagnostics industry. As the only player with significant experience in the Public-Private Partnership model, Krsnaa’s unparalleled expertise, combined with our hospital infrastructure, positions us to accelerate growth at an unprecedented pace. This powerful collaboration ensures we are uniquely poised to capitalize on opportunities faster and more efficiently than any other player in the market. With this partnership we are eliminating the barriers of fragmented healthcare by integrating diagnostics and treatment under one roof. This partnership will enhance patient care as well as work towards setting a new benchmark for cancer and cardiac diagnostics and treatment in India thanks to its first of a kind partnership model.”
